Annual Cash & Cash Equivalents
$22.41 M
-$26.42 M-54.11%
December 31, 2023
Summary
- As of February 7, 2025, ALXO annual cash & cash equivalents is $22.41 million, with the most recent change of -$26.42 million (-54.11%) on December 31, 2023.
- During the last 3 years, ALXO annual cash & cash equivalents has fallen by -$411.81 million (-94.84%).
- ALXO annual cash & cash equivalents is now -94.84% below its all-time high of $434.22 million, reached on December 31, 2020.
Performance
ALXO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$16.10 M
+$568.00 K+3.66%
September 30, 2024
Summary
- As of February 7, 2025, ALXO quarterly cash and cash equivalents is $16.10 million, with the most recent change of +$568.00 thousand (+3.66%) on September 30, 2024.
- Over the past year, ALXO quarterly cash and cash equivalents has dropped by -$3.48 million (-17.78%).
- ALXO quarterly cash and cash equivalents is now -96.29% below its all-time high of $434.22 million, reached on December 31, 2020.
Performance
ALXO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ALXO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -54.1% | -17.8% |
| 3 y3 years | -94.8% | -89.9% |
| 5 y5 years | +171.2% | -96.3% |
ALXO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -93.8% | at low | -95.6% | +14.7% |
| 5 y | 5-year | -94.8% | +148.5% | -96.3% | +78.6% |
| alltime | all time | -94.8% | +171.2% | -96.3% | +78.6% |
ALX Oncology Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $16.10 M(+3.7%) |
| Jun 2024 | - | $15.53 M(+10.6%) |
| Mar 2024 | - | $14.04 M(-37.3%) |
| Dec 2023 | $22.41 M(-54.1%) | $22.41 M(+14.4%) |
| Sep 2023 | - | $19.58 M(-48.5%) |
| Jun 2023 | - | $38.04 M(-39.8%) |
| Mar 2023 | - | $63.19 M(+29.4%) |
| Dec 2022 | $48.82 M | $48.82 M(-0.5%) |
| Sep 2022 | - | $49.05 M(-26.1%) |
| Jun 2022 | - | $66.38 M(-58.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $159.09 M(-56.3%) |
| Dec 2021 | $363.67 M(-16.2%) | $363.67 M(-5.6%) |
| Sep 2021 | - | $385.15 M(-6.1%) |
| Jun 2021 | - | $409.96 M(-4.6%) |
| Mar 2021 | - | $429.86 M(-1.0%) |
| Dec 2020 | $434.22 M(+4715.6%) | $434.22 M(+67.3%) |
| Sep 2020 | - | $259.48 M(+164.5%) |
| Jun 2020 | - | $98.10 M(-6.6%) |
| Mar 2020 | - | $105.03 M(+1064.9%) |
| Dec 2019 | $9.02 M(+9.1%) | $9.02 M |
| Dec 2018 | $8.26 M | - |
FAQ
- What is ALX Oncology Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ALX Oncology Holdings?
- What is ALX Oncology Holdings annual cash & cash equivalents year-on-year change?
- What is ALX Oncology Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for ALX Oncology Holdings?
- What is ALX Oncology Holdings quarterly cash and cash equivalents year-on-year change?
What is ALX Oncology Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of ALXO is $22.41 M
What is the all time high annual cash & cash equivalents for ALX Oncology Holdings?
ALX Oncology Holdings all-time high annual cash & cash equivalents is $434.22 M
What is ALX Oncology Holdings annual cash & cash equivalents year-on-year change?
Over the past year, ALXO annual cash & cash equivalents has changed by -$26.42 M (-54.11%)
What is ALX Oncology Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ALXO is $16.10 M
What is the all time high quarterly cash and cash equivalents for ALX Oncology Holdings?
ALX Oncology Holdings all-time high quarterly cash and cash equivalents is $434.22 M
What is ALX Oncology Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, ALXO quarterly cash and cash equivalents has changed by -$3.48 M (-17.78%)